William N. William
Beneficência Portuguesa de São Paulo(BR)Fleury S.A. (Brazil)(BR)Sociedade Brasileira de Oncologia Clínica(BR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Head and Neck Cancer Studies, Cancer Immunotherapy and Biomarkers, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics
Most-Cited Works
- → Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study(2016)1,065 cited
- → Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing(2014)1,000 cited
- → Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint(2014)611 cited
- → Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial(2021)588 cited
- → A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition(2015)576 cited